Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Scientists launch largest Real-World study of rare angiosarcoma

NCT ID NCT06375941

Knowledge-focused Sponsor: Italian Sarcoma Group Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study follows 250 people with localized angiosarcoma, a rare cancer of blood vessels. Researchers will collect information on tumor features, patient history, and standard treatments used in everyday practice. The goal is to better understand the disease and guide future care, but no new treatment is being tested.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If this study succeeds, it could help doctors better understand angiosarcoma and improve future treatment guidelines.
What could go wrong
This is an observational study, not a treatment trial. It collects data only, so it won't directly test or provide any new therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 250 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2024

Expected to finish

Apr 2034

An estimate. End dates often move.

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

* pathological diagnosis of AS; * any site of origin; * any age; * primary, localized, resectable disease.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * pathological diagnosis of AS; * any site of origin; * any age; * primary, localized, resectable disease. Exclusion Criteria: NA

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Angiosarcoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

angiosarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Angiosarcoma

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    19 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • A.O.U. Careggi

    NOT_YET_RECRUITING

    Florence, 50134, Italy

  • AOU San Luigi Gonzaga

    RECRUITING

    Orbassano, Torino, 10043, Italy

  • ASL Ospedale San Giovanni Bosco

    RECRUITING

    Torino, 10154, Italy

  • Centro Riferimento Oncologico CRO

    RECRUITING

    Aviano, Pordenone, 33081, Italy

  • Fondazione Irccs San Gerardo Dei Tintori

    NOT_YET_RECRUITING

    Monza, 20900, Italy

  • Fondazione Policlinico Campus Biomedico

    RECRUITING

    Roma, 00128, Italy

  • IOV Istituto Oncologico Veneto IRCCS

    RECRUITING

    Padova, 35128, Italy

  • IRCCS Istituti Fisioterapici Ospitalieri

    NOT_YET_RECRUITING

    Roma, 00144, Italy

  • IRCCS Istituto Europeo di Oncologia

    NOT_YET_RECRUITING

    Milan, 20141, Italy

  • IRCCS Istituto Nazionale Tumori - Milano

    RECRUITING

    Milan, 20133, Italy

  • Istituto Clinico Humanitas Research Hospital IRCCS

    NOT_YET_RECRUITING

    Rozzano, Milano, 20089, Italy

  • Istituto Nazionale Tumori_Fondazione "G.Pascale"

    RECRUITING

    Naples, 80131, Italy

  • Istituto Ortopedico Rizzoli IOR

    RECRUITING

    Bologna, 40136, Italy

  • Istituto Tumori "Giovanni Paolo II" I.R.C.C.S.

    NOT_YET_RECRUITING

    Bari, 70124, Italy

  • Nuovo Ospedale di Prato - S. Stefano

    RECRUITING

    Prato, 59100, Italy

  • Ospedale Policlinico san Martino IRCCS

    RECRUITING

    Genova, 16132, Italy

  • Ospedale di Trento

    NOT_YET_RECRUITING

    Trento, 38123, Italy

  • Policlinico "Paolo Giaccone"

    RECRUITING

    Palermo, 90127, Italy

  • Policlinico "Sant'Orsola-Malpighi"

    RECRUITING

    Bologna, 40138, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.